0 CHECKOUT

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

  • ID: 3412708
  • August 2015
  • 1249 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 4SC AG
  • BIND Therapeutics, Inc.
  • Eisai Co., Ltd.
  • Gilead Sciences, Inc.
  • medac GmbH
  • Pharma Mar, S.A.
  • MORE

The report ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 4SC AG
  • BIND Therapeutics, Inc.
  • Eisai Co., Ltd.
  • Gilead Sciences, Inc.
  • medac GmbH
  • Pharma Mar, S.A.
  • MORE

Introduction

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Overview

Therapeutics Development

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics under Development by Companies

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics under Investigation by Universities/Institutes

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Products Glance

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Products under Development by Companies

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Products under Investigation by Universities/Institutes

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Companies Involved in Therapeutics Development

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics Assessment

Drug Profiles

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Recent Pipeline Updates

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), H2 2015

Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Development by Companies, H2 2015 (Contd..1)

Number of Products under Development by Companies, H2 2015 (Contd..2)

Number of Products under Development by Companies, H2 2015 (Contd..3)

Number of Products under Development by Companies, H2 2015 (Contd..4)

Number of Products under Development by Companies, H2 2015 (Contd..5)

Number of Products under Development by Companies, H2 2015 (Contd..6)

Number of Products under Development by Companies, H2 2015 (Contd..7)

Number of Products under Development by Companies, H2 2015 (Contd..8)

Number of Products under Development by Companies, H2 2015 (Contd..9)

Number of Products under Development by Companies, H2 2015 (Contd..10)

Number of Products under Development by Companies, H2 2015 (Contd..11)

Number of Products under Development by Companies, H2 2015 (Contd..12)

Number of Products under Development by Companies, H2 2015 (Contd..13)

Number of Products under Investigation by Universities/Institutes, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)

Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Development, H2 2015

Comparative Analysis by Unknown Stage Development, H2 2015

Products under Development by Companies, H2 2015

Products under Development by Companies, H2 2015 (Contd..1)

Products under Development by Companies, H2 2015 (Contd..2)

Products under Development by Companies, H2 2015 (Contd..3)

Products under Development by Companies, H2 2015 (Contd..4)

Products under Development by Companies, H2 2015 (Contd..5)

Products under Development by Companies, H2 2015 (Contd..6)

Products under Development by Companies, H2 2015 (Contd..7)

Products under Development by Companies, H2 2015 (Contd..8)

Products under Development by Companies, H2 2015 (Contd..9)

Products under Development by Companies, H2 2015 (Contd..10)

Products under Development by Companies, H2 2015 (Contd..11)

Products under Development by Companies, H2 2015 (Contd..12)

Products under Development by Companies, H2 2015 (Contd..13)

Products under Development by Companies, H2 2015 (Contd..14)

Products under Development by Companies, H2 2015 (Contd..15)

Products under Development by Companies, H2 2015 (Contd..16)

Products under Development by Companies, H2 2015 (Contd..17)

Products under Development by Companies, H2 2015 (Contd..18)

Products under Development by Companies, H2 2015 (Contd..19)

Products under Development by Companies, H2 2015 (Contd..20)

Products under Development by Companies, H2 2015 (Contd..21)

Products under Development by Companies, H2 2015 (Contd..22)

Products under Development by Companies, H2 2015 (Contd..23)

Products under Development by Companies, H2 2015 (Contd..24)

Products under Investigation by Universities/Institutes, H2 2015

Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)

Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)

Products under Investigation by Universities/Institutes, H2 2015 (Contd..3)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by 4SC AG, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AB Science SA, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AbbVie Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Acetylon Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Actinium Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Advenchen Laboratories, LLC, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Affichem SA, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Agios Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AIMM Therapeutics B.V., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Akinion Pharmaceuticals AB, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Altor BioScience Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Amgen Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Antigen Express, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by APIM Therapeutics AS, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Aprea AB, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Aptose Biosciences Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Ariad Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Arno Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Arog Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Array BioPharma Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Ascenta Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Astellas Pharma Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Astex Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AstraZeneca Plc, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Atara Biotherapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bayer AG, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BerGenBio AS, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BIND Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bio-Cancer Treatment International Limited, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bio-Path Holdings, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BioInvent International AB, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BioLineRx, Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Boehringer Ingelheim GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Boston Biomedical, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bristol-Myers Squibb Company, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Calithera Biosciences, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cancer Therapeutics CRC Pty Ltd, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cantargia AB, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cantex Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celator Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celgene Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellceutix Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celldex Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellectis S.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellerant Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celyad, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Clevexel Pharma SAS, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Constellation Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cornerstone Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Critical Outcome Technologies Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by CTI BioPharma Corp., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by CureTech Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cyclacel Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Daiichi Sankyo Company, Limited, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by DC Prime B.V., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Debiopharm International S.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Deciphera Pharmaceuticals, LLC, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by DiNonA Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Egenix, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eisai Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eli Lilly and Company, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by EntreChem, S.L., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by EpiZyme, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Erytech Pharma SA, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Esperance Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eureka Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Exelixis, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fate Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Formula Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fortress Biotech, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fujifilm Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Gamida Cell Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genentech, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genoscience Pharma, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genosco, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genzyme Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Gilead Sciences, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by GlaxoSmithKline Plc, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by GlycoMimetics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Golden Biotechnology Corp., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Hybrigenics S.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Igenica Biotherapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Ignyta, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Immune System Key Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by ImmunGene, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by ImmunoGen, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Incyte Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Interprotein Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Jasco Pharmaceuticals, LLC., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Johnson & Johnson, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Juno Therapeutics Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by JW Pharmaceutical Corporation, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Kainos Medicine, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by KaloBios Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Karyopharm Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Kiadis Pharma B.V., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Kinex Pharmaceuticals, LLC, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Kolltan Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Komipharm International Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Lead Discovery Center GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Les Laboratoires Servier SAS, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MacroGenics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MaxCyte, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by medac GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MediGene AG, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MedImmune, LLC, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MEI Pharma, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Merck & Co., Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Merus B.V., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Millennium Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Mirna Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by MolMed S.p.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by NantKwest, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Nerviano Medical Sciences S.r.l., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Neumedicines Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Novartis AG, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by NuCana BioMed Limited, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by OncoImmune, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Onconova Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Onyx Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Otsuka Holdings Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Oxford BioTherapeutics Ltd, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by OXiGENE, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Pfizer Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Pharma Mar, S.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Pharmacyclics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Pharmedartis GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Philogen S.p.A., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Polaris Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Resverlogix Corp., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Rich Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sanofi, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sareum Holdings Plc, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Seattle Genetics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sellas Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Selvita SA, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Senhwa Biosciences, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sentinel Oncology Limited, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sorrento Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by SpectraMab GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Stemline Therapeutics, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Sunesis Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Syndax Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by SYNIMMUNE GmbH, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Synta Pharmaceuticals Corp., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Syros Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by TaiGen Biotechnology Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Tautatis Incorporated, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by TetraLogic Pharmaceuticals, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Teva Pharmaceutical Industries Limited, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Theravectys SA, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Threshold Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Toko Pharmaceutical Industries Co., Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Tolero Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Tragara Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Trillium Therapeutics Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Verastem, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Vichem Chemie Research Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by VioQuest Pharmaceuticals, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Viralytics Ltd., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Xencor, Inc., H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Xenetic Biosciences plc, H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Stage and Target, H2 2015

Number of Products by Stage and Mechanism of Action, H2 2015

Number of Products by Stage and Route of Administration, H2 2015

Number of Products by Stage and Molecule Type, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Therapeutics - Recent Pipeline Updates, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..1), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..2), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..3), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..4), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..5), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..6), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..7), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..8), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..9), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..10), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects (Contd..11), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products, H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products (Contd..1), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products (Contd..2), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products (Contd..3), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products (Contd..4), H2 2015

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products (Contd..5), H2 2015

List of Figures

Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), H2 2015

Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Comparative Analysis, H2 2015

Number of Products under Development by Companies, H2 2015

Number of Products under Investigation by Universities/Institutes, H2 2015

Comparative Analysis by Late Stage Development, H2 2015

Comparative Analysis by Clinical Stage Development, H2 2015

Comparative Analysis by Early Stage Products, H2 2015

Assessment by Monotherapy Products, H2 2015

Assessment by Combination Products, H2 2015

Number of Products by Top 10 Targets, H2 2015

Number of Products by Stage and Top 10 Targets, H2 2015

Number of Products by Top 10 Mechanism of Actions, H2 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015

Number of Products by Top 10 Routes of Administration, H2 2015

Number of Products by Stage and Top 10 Routes of Administration, H2 2015

Number of Products by Top 10 Molecule Types, H2 2015

Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

4SC AG
AB Science SA
AbbVie Inc.
Acetylon Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
Advenchen Laboratories, LLC
Affichem SA
Agios Pharmaceuticals, Inc.
AIMM Therapeutics B.V.
Akinion Pharmaceuticals AB
Altor BioScience Corporation
Amgen Inc.
Antigen Express, Inc.
APIM Therapeutics AS
Aprea AB
Aptose Biosciences Inc.
Ariad Pharmaceuticals, Inc.
Arno Therapeutics, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Ascenta Therapeutics, Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
Atara Biotherapeutics, Inc.
AVEO Pharmaceuticals, Inc.
Bayer AG
BerGenBio AS
BIND Therapeutics, Inc.
Bio-Cancer Treatment International Limited
Bio-Path Holdings, Inc.
BioInvent International AB
BioLineRx, Ltd.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Calithera Biosciences, Inc.
Cancer Therapeutics CRC Pty Ltd
Cantargia AB
Cantex Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc.
Celgene Corporation
Cellceutix Corporation
Celldex Therapeutics, Inc.
Cellectis S.A.
Cellerant Therapeutics, Inc.
Celyad
Clevexel Pharma SAS
Constellation Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CTI BioPharma Corp.
CureTech Ltd.
Cyclacel Pharmaceuticals, Inc.
Daiichi Sankyo Company, Limited
DC Prime B.V.
Debiopharm International S.A.
Deciphera Pharmaceuticals, LLC
DiNonA Inc.
Egenix, Inc.
Eisai Co., Ltd.
Eli Lilly and Company
EntreChem, S.L.
EpiZyme, Inc.
Erytech Pharma SA
Esperance Pharmaceuticals, Inc.
Eureka Therapeutics, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Fate Therapeutics, Inc.
Formula Pharmaceuticals, Inc.
Fortress Biotech, Inc.
Fujifilm Corporation
Gamida Cell Ltd.
Genentech, Inc.
Genoscience Pharma
Genosco
Genzyme Corporation
Gilead Sciences, Inc.
GlaxoSmithKline Plc
GlycoMimetics, Inc.
Golden Biotechnology Corp.
Hybrigenics S.A.
Igenica Biotherapeutics, Inc.
Ignyta, Inc.
Immune System Key Ltd.
ImmunGene, Inc.
ImmunoGen, Inc.
Inbiopro Solutions Pvt. Ltd.
Incyte Corporation
Interprotein Corporation
Jasco Pharmaceuticals, LLC.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
Juno Therapeutics Inc.
JW Pharmaceutical Corporation
Kainos Medicine, Inc.
KaloBios Pharmaceuticals, Inc.
Karyopharm Therapeutics, Inc.
Kiadis Pharma B.V.
Kinex Pharmaceuticals, LLC
Kolltan Pharmaceuticals, Inc.
Komipharm International Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Lead Discovery Center GmbH
Les Laboratoires Servier SAS
MacroGenics, Inc.
MaxCyte, Inc.
medac GmbH
MediGene AG
MedImmune, LLC
MEI Pharma, Inc.
Merck & Co., Inc.
Merus B.V.
Millennium Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
MolMed S.p.A.
NantKwest, Inc.
Nerviano Medical Sciences S.r.l.
Neumedicines Inc.
Novartis AG
NuCana BioMed Limited
OncoImmune, Inc.
Onconova Therapeutics, Inc.
Ono Pharmaceutical Co., Ltd.
Onyx Pharmaceuticals, Inc.
Otsuka Holdings Co., Ltd.
Oxford BioTherapeutics Ltd
OXiGENE, Inc.
Pfizer Inc.
Pharma Mar, S.A.
Pharmacyclics, Inc.
Pharmedartis GmbH
Philogen S.p.A.
Polaris Pharmaceuticals, Inc.
Resverlogix Corp.
Rich Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Seattle Genetics, Inc.
Sellas Inc.
Selvita SA
Senhwa Biosciences, Inc.
Sentinel Oncology Limited
Sorrento Therapeutics, Inc.
SpectraMab GmbH
Stemline Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Sunesis Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.
SYNIMMUNE GmbH
Synta Pharmaceuticals Corp.
Syros Pharmaceuticals, Inc.
TaiGen Biotechnology Co., Ltd.
Tautatis Incorporated
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Limited
Theravectys SA
Threshold Pharmaceuticals, Inc.
Toko Pharmaceutical Industries Co., Ltd.
Tolero Pharmaceuticals, Inc.
Tragara Pharmaceuticals, Inc.
Trillium Therapeutics Inc.
Verastem, Inc.
Vichem Chemie Research Ltd.
VioQuest Pharmaceuticals, Inc.
Viralytics Ltd.
Xencor, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amgen Inc.
  • Quest Diagnostics, Inc.
  • Roche Diagnostics Ltd.
  • Clariant International Ltd.
  • IGen Biotech SL
  • Abbott Laboratories Ltd.